000 03349cam a22003615c 4500
001 85816
003 ES-MaUEC
005 20230207040529.0
007 cr nn 008mamaa
008 160425s2016 gw | s |||| 0|eng d
020 _a9783319313412
040 _aES-MaUEC
050 4 _aRC280.P7
_b2016 EB
082 0 4 _a616.6
245 0 0 _aManaging Metastatic Prostate Cancer In Your Urological Oncology Practice
_cedited by KC Balaji
260 _aCham
_bSpringer International Publishing
_c2016
300 _a1 recurso en línea (XIII, 280 p.)
_b35 ilustraciones, 31 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aIntroduction -- Pathophysiology of Castration-Resistant Prostate Cancer -- Androgen Receptor Signaling in Castration Resistant Prostate Cancer -- Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer -- Predictive Models in Castration Resistant Prostate Cancer -- Docetaxel in Advanced and Castration Resistant Prostate Cancer -- Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate -- Cancer Vaccines in Castration Resistant Prostate Cancer {u2014} An evolution in design -- Abiraterone for the treatment of mCRPC -- Enzalutamide in Metastatic Castration Resistant Prostate Cancer -- Radium-223 in Metastatic Castrate Resistant Prostate Cancer -- Cabazitaxel for the Treatment of Prostate Cancer -- Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer -- Bone Preservation Strategies for Men on Androgen Deprivation Therapy -- Novel Therapies in Castration-Resistant Prostate Cancer
520 3 _aThis text provides a comprehensive review of pathophysiology, molecular and cell biology aspects of CRPC, discusses all major clinical trials that have led to approval of 6 new drugs since 2004, explores the role of bone preservation strategies, in depth analysis of combination and sequencing strategies, outlines upcoming novel drugs and trends in research, and stresses the role of palliative care in this incurable disease. Managing Metastatic Prostate Cancer in Your Urological Oncology Practice will serve as a very useful resource for physicians and researchers dealing with, and interested in prostate cancer. It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and will include the most up to date scientific and clinical information
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
650 7 _aPróstata
_xCáncer
_0comprobar BNE19901355947
_2embne
_9182337
700 1 _aBalaji, K. C.
_eeditor literario
_0Local
_999047
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-31341-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319313412
907 _a.b12950944
_b10-10-17
_c21-11-16
988 _aSpringer_Medicine_2016
998 _am
_a_alco
_a_vill
_b04-04-17
_cm
_dz
_ek
_feng
_ggw
_h0
945 _aRC280.P7 M363 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11593908
_z06-04-17
999 _c85816
_d85816
_x1